1. November 30, 2021

    Give your opinion on genetically modified vaccines to treat hepatitis B

    The FPS Public Health and FAMHP would like to invite you to take part in the public consultation on a clinical trial testing the genetically modified vaccines ChAd155-hIi-HBV and MVA-HBV for the treatment of infections with the hepatitis B virus (HBV). The public consultation will run from 27 November 2021 to 27 December 2021.

    Source: FAMHP

    Read more

  2. November 25, 2021

    12th International Symposium of Drug Analysis - 32nd International Symposium on Pharmaceutical and Biomedical Analysis

    The Organising Committee of the International Symposium DA-PBA 2022 is pleased to announce its 2022 edition, which will take place in Mons, Belgium, from September 11-14, 2022. 

    This symposium will be a joint meeting of two distinguished series: the 12th International Symposium on Drug Analysis and the 32nd International Symposium on Pharmaceutical and Biomedical Analysis.

    Read more

  3. November 23, 2021

    Clinical Trials Regulation (CTR): specific webinar for small and medium-sized enterprises (SMEs) and academic sponsors

    In the context of the preparation of the implementation of the Clinical Trials Regulation (CTR), which will come into force on 31 January 2022, a specific webinar for SMEs and academic sponsors on key aspects of the CTR and the new processes via the Clinical Trials Information System (CTIS) for clinical trial application submissions will be organised on 29 November 2021.

    Source: FAMHP

    Read more

  4. November 22, 2021

    Coronavirus: updated timelines for applications for COVID-19 clinical trials

    Since 25 March 2020, shortened deadlines have been used for applications for clinical trials with medicinal products for the treatment or prevention of COVID-19. As the vaccination campaign has reached the majority of the population, these reduced timelines are now extended to 15 calendar days.

    Source: FAMHP

    Read more

  5. November 19, 2021

    Coronavirus: monthly update of COVID-19 vaccines 18 November 2021

    Coronavirus: maandelijks overzicht bijwerkingen COVID-19-vaccins van 18 november 2021

    Coronavirus : aperçu mensuel des effets indésirables des vaccins contre la COVID-19 du 18 novembre 2021

    Source: FAMHP

    Read more

  6. November 19, 2021

    International week of awareness for rational use of antibiotics

    Van 18 tot 24 november 2021 loopt de internationale week van de sensibilisering voor rationeel gebruik van antibiotica.

    La semaine mondiale de sensibilisation à l’usage rationnel des antibiotiques se déroule du 18 au 24 novembre 2021.

    Source: FAMHP

    Read more

  7. November 10, 2021

    Deadlines for the submission of dossiers during end-of-year period

    During the end-of-year period, the FAMHP will be closed from Monday 27 December 2021 through Friday 31 December 2021. Deadlines have been set for the submission of different types of dossiers.

    Source: FAMHP

    Read more

  8. November 10, 2021

    PRAC November 2021: updates on COVID-19 vaccines and conclusion of safety signal for Imbruvica

    During its November 2021 meeting, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has made un update on COVID-19 vaccines and concluded a safety signal for Imbruvica.

    Source: FAMHP

    Read more

  9. November 4, 2021

    MedSafetyWeek: help make vaccines safer by reporting suspected side effects

    Het FAGG neemt samen met bevoegde autoriteiten uit 64 landen deel aan een internationale sociale mediacampagne die het belang van bijwerkingen na vaccinatie melden in de verf zet. 

    L'AFMPS, en collaboration avec les autorités compétentes de 64 pays, participe à une campagne internationale sur les médias sociaux soulignant l'importance de déclarer les effets indésirables après une vaccination. 

    Source: FAMHP

    Read more

  10. November 4, 2021

    Give your opinion on a genetically modified vaccine to treat colorectal cancer

    The FPS Public Health and FAMHP would like to invite you to take part in the public consultation on a clinical trial testing the genetically modified vaccine VSV-GP128 to treat colorectal cancer. The public consultation will run from 1 November 2021 to 1 December 2021.

    Source: FAMHP

    Read more